Predicting the public health impact of bivalent vaccines and nirmatrelvir-ritonavir against COVID-19
Description
CONCLUSIONS: These findings suggest prioritizing uptake of bivalent boosters and nirmatrelvir-ritonavir among the oldest age groups would be efficient and have substantial public health impact in reducing the burden of severe COVID-19, but would not
